Clegg LE, Stepanov O, Schmidt H, Tang W, et al. Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19. Antimicrob Agents Chemother 2024;68:e0158723.
PMID: 38534112